Results 41 to 50 of about 5,851 (166)

Moyamoya Disease, Which is Rare in Infancy: A Case Report

, 2023
Moyamoya disease etiology is an undetermined vasculopathy and is mainly thought to affect the Internal Carotid Artery and Wills circle. An 8-month-old patient without any underlying disease was referred to our hospital with sudden extreme right ...
Derya Bako, Edin Botan, Ayşen Durak, Merve Boyraz   +3 more
core   +1 more source

Enfermedad de moyamoya [PDF]

, 2016
La enfermedad de moyamoya es una arteriopatía estenosante progresiva que implica la circulación cerebral y que predispone a accidentes cerebrovasculares.
Luzuriaga Rivera,Celia, Soler Cifuentes,María Gema, Buller Viqueira,Eva   +2 more
core   +1 more source

Quantification of High-Resolution Contrast-Enhanced T1-Weighted Vessel Wall MRI for Predicting Disease Progression in Moyamoya Disease

Brain Sciences
Objective: In moyamoya disease (MMD), the internal carotid and proximal cerebral arteries narrow, potentially leading to stroke or hemorrhage from fragile collaterals.
Kateryna Goloshchapova, Patrick Haas, Daniel Vogl, Lucas Wiggenhauser, Helene Hurth, Florian Hennersdorf, Benjamin Bender, Till-Karsten Hauser, Marcos Tatagiba, Nadia Khan, Constantin Roder   +10 more
doaj   +1 more source

Anaesthesia and Moyamoya Disease [PDF]

Anaesthesia and Intensive Care, 1995
link_to_subscribed_fulltext
Henderson, MA, Irwin, MG
openaire   +3 more sources

Coincidence of Concentric Vessel-Wall Contrast Enhancement in Moyamoya Disease and Acute Postoperative Ischemic Stroke During Revascularization Procedures

Brain Sciences
Background: Concentric vessel-wall contrast enhancement (VW-CE) of the terminal carotid artery and its proximal branches may be linked to ischemic strokes, disease activity and progression in Moyamoya disease (MMD).
Patrick Haas, Till-Karsten Hauser, Lucas Moritz Wiggenhauser, Leonie Zerweck, Marcos Tatagiba, Nadia Khan, Constantin Roder   +6 more
doaj   +1 more source

Moyamoya syndrome presenting in an adult with Down syndrome: A case report with a literature review

Radiology Case Reports, 2022
Moyamoya disease is an unusual occlusive cerebrovascular condition commonly seen in children, marked by stenosis of the internal carotid artery and circle of Willis, causing, cerebral ischemia.
Mohamed Hamid, MD, Soukaina Cherradi, MD, Ahmed Bourazza, MD   +2 more
doaj   +1 more source

Moyamoya disease and syndrome: a review

, 2022
Moyamoya disease is a chronic occlusive cerebrovascular disease that is non-inflammatory and non-atherosclerotic. It is characterized by endothelial hyperplasia and fibrosis of the intracranial portion of the carotid artery and its proximal branches ...
Luana A. Maranha Gatto (5379989), Zeferino Demartini Jr. (12702587), Renato Puppi Munhoz (6304718), Gelson Luis Koppe (4618165), Alex Roman (12702593), Bernardo CA. Teixeira (12702590)   +5 more
core   +1 more source

Genetics and Biomarkers of Moyamoya Disease: Significance of as a Susceptibility Gene [PDF]

Journal of Stroke, 2014
Moyamoya disease is characterized by a progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain.
Miki Fujimura, Shinya Sonobe, Yasuo Nishijima, Kuniyasu Niizuma, Hiroyuki Sakata, Shigeo Kure, Teiji Tominaga   +6 more
doaj   +1 more source

Vascular risk profile and changes of arterial hypertension after surgical revascularization in adult Moyamoya patients

Scientific Reports
Moyamoya disease (MMD) is a rare stenoocclusive cerebral vasculopathy often treated by neurosurgical revascularization using extracranial-intracranial bypasses to prevent ischemic or hemorrhagic events.
Patrick Haas, Lucas Moritz Wiggenhauser, Jonas Tellermann, Helene Hurth, Daniel Feucht, Marcos Tatagiba, Nadia Khan, Constantin Roder   +7 more
doaj   +1 more source

Identifying Diagnostic Thresholds for the Assessment of Cerebrovascular Reserve Impairment in Moyamoya Disease: CO₂-Triggered BOLD-MRI and [¹⁵O]water-PET with Acetazolamide Challenge

Brain Sciences
Background: Assessment of cerebrovascular reserve capacity (CVRC) is central to treatment planning in adult Moyamoya disease. [15O]-water-PET with acetazolamide challenge (PET-ACZ) serves as the reference standard but is resource-intensive and not ...
Patrick Haas, Lucas Moritz Wiggenhauser, Johannes Spang, Leonie Zerweck, Christian Volz, Marcos Tatagiba, Nadia Khan, Philipp T. Meyer, Till-Karsten Hauser, Constantin Roder   +9 more
doaj   +1 more source